Access to antiretroviral therapy in HIV-infected injection drug users

Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.

The Journal of antimicrobial chemotherapy·2020

Risk of cardiovascular disease in patients with HIV infection undergoing antiretroviral therapy.

Revista clinica espanola·2019

Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.

Current HIV research·2019

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

The Journal of antimicrobial chemotherapy·2016

The role of tenofovir alafenamide in future HIV management.

HIV medicine·2016

Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen.

HIV medicine·2014

Effects of semaglutide on subclinical cardiovascular health in people with HIV.

AIDS (London, England)·2026

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

AIDS (London, England)·2026

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

AIDS (London, England)·2026

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

AIDS (London, England)·2026

Efficacy of dolutegravir or bictegravir-containing therapy in a real-life cohort of people with HIV-1 sub-subtype A6.

AIDS (London, England)·2026

Sex-modulated associations between cytomegalovirus cell-associated DNA and cognition in people with HIV on ART.

AIDS (London, England)·2026

VirPLM: Antigenic prediction of influenza A/H3N2 viruses with a fine-tuned protein language model.

Bioinformatics (Oxford, England)·2026

Mechanism of IH promoting pulmonary arterial hypertension through ROS-NLRP3 inflammasome mediated endothelial cell pyroptosis.

Experimental lung research·2026

IgE-Binding Bacterial Components Not Yet Documented in the Allergen Databases and Their Allergenic Mechanisms: An EAACI Position Paper.

Allergy·2026

Multifocal mucocutaneous herpes simplex virus type 1 infection temporally associated with seasonal influenza vaccination in a young adult without a known immunocompromising condition: A case report.

Human vaccines & immunotherapeutics·2026

ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review).

International journal of molecular medicine·2026

Organelle-centered ISG15 biology: distinguishing covalent ISGylation from interferon-associated responses.

Frontiers in immunology·2026

Related Experiment Videos

Access to antiretroviral therapy in HIV-infected injection drug users

Related Concept Videos

Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.

Risk of cardiovascular disease in patients with HIV infection undergoing antiretroviral therapy.

Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

The role of tenofovir alafenamide in future HIV management.

Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen.

Effects of semaglutide on subclinical cardiovascular health in people with HIV.

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

Efficacy of dolutegravir or bictegravir-containing therapy in a real-life cohort of people with HIV-1 sub-subtype A6.

Sex-modulated associations between cytomegalovirus cell-associated DNA and cognition in people with HIV on ART.

VirPLM: Antigenic prediction of influenza A/H3N2 viruses with a fine-tuned protein language model.

Mechanism of IH promoting pulmonary arterial hypertension through ROS-NLRP3 inflammasome mediated endothelial cell pyroptosis.

IgE-Binding Bacterial Components Not Yet Documented in the Allergen Databases and Their Allergenic Mechanisms: An EAACI Position Paper.

Multifocal mucocutaneous herpes simplex virus type 1 infection temporally associated with seasonal influenza vaccination in a young adult without a known immunocompromising condition: A case report.

ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review).

Organelle-centered ISG15 biology: distinguishing covalent ISGylation from interferon-associated responses.

Related Experiment Videos

Access to antiretroviral therapy in HIV-infected injection drug users

Related Concept Videos

Related Articles